Log In
BCIQ
Print this Print this
 

Retaine MGD Ophthalmic Emulsion (Cationorm) (Nova23006)

Also known as: Catinorm

  Manage Alerts
Collapse Summary General Information
Company Santen Pharmaceutical Co. Ltd.
DescriptionActive-free ophthalmic cationic emulsion
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDry eye
Indication DetailsTreat mild to moderate dry eye conditions
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$134.2M

$134.2M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/02/2012

$134.2M

$134.2M

0

Get a free BioCentury trial today